Parotid gland injections of botulinum toxin a are effective in treating sialorrhea in amyotrophic lateral sclerosis
- PMID: 19078785
- DOI: 10.1097/01.cnd.0000188865.88167.62
Parotid gland injections of botulinum toxin a are effective in treating sialorrhea in amyotrophic lateral sclerosis
Abstract
Objective: : The objective of this study was to determine the safety and efficacy of botulinum toxin A in ameliorating refractory sialorrhea and improving quality of life in patients with amyotrophic lateral sclerosis.
Materials and methods: : Six patients with bulbar ALS received bilateral parotid gland injections of botulinum toxin A.
Results: : No adverse effects occurred. Tissue use decreased in 5 of 7 patients at a dose of 10 units and in 3 of 4 patients at a dose of 20 units. Self-reported quality of life did not change in most.
Conclusions: : Parotid gland injections of botulinum toxin appear safe and may be helpful in some patients with ALS for the treatment of sialorrhea.
Similar articles
-
Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis.Muscle Nerve. 2006 Aug;34(2):235-7. doi: 10.1002/mus.20545. Muscle Nerve. 2006. PMID: 16583370 Clinical Trial.
-
Botulinum toxin type A for the treatment of sialorrhoea in amyotrophic lateral sclerosis: a clinical and neurophysiological study.Amyotroph Lateral Scler. 2010 Aug;11(4):359-63. doi: 10.3109/17482960903264998. Amyotroph Lateral Scler. 2010. PMID: 19929745
-
Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview.Toxicon. 2015 Dec 1;107(Pt A):129-40. doi: 10.1016/j.toxicon.2015.08.014. Epub 2015 Aug 30. Toxicon. 2015. PMID: 26327120 Review.
-
Volume matters: the influence of different botulinum toxin-A dilutions for sialorrhea in amyotrophic lateral sclerosis.Muscle Nerve. 2013 Feb;47(2):276-8. doi: 10.1002/mus.23692. Epub 2012 Dec 28. Muscle Nerve. 2013. PMID: 23281147
-
Salivary gland application of botulinum toxin for the treatment of sialorrhea.Med Oral Patol Oral Cir Bucal. 2007 Nov 1;12(7):E511-7. Med Oral Patol Oral Cir Bucal. 2007. PMID: 17978775 Review.
Cited by
-
Sialorrhea in patients with ALS: current treatment options.Degener Neurol Neuromuscul Dis. 2019 Mar 20;9:19-26. doi: 10.2147/DNND.S168353. eCollection 2019. Degener Neurol Neuromuscul Dis. 2019. PMID: 31118868 Free PMC article.
-
Patient-reported problematic symptoms in an ALS treatment trial.Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(3-4):198-205. doi: 10.3109/21678421.2015.1131831. Epub 2016 Jan 29. Amyotroph Lateral Scler Frontotemporal Degener. 2016. PMID: 26824413 Free PMC article. Clinical Trial.
-
Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis.Cochrane Database Syst Rev. 2022 May 20;5(5):CD006981. doi: 10.1002/14651858.CD006981.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593746 Free PMC article.
-
The use of botulinum toxin injections to manage drooling in amyotrophic lateral sclerosis/motor neurone disease: a systematic review.Dysphagia. 2014 Aug;29(4):500-8. doi: 10.1007/s00455-014-9535-8. Epub 2014 May 22. Dysphagia. 2014. PMID: 24847964
LinkOut - more resources
Full Text Sources
Miscellaneous